Arthur A. Levin, Director at Avidity Biosciences, Inc. (RNA), sold 107,500 shares at $47.62 ($5.1M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Scheduled sale ($5.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |
| RNA | SELL | 2024-10-23 | $233K | — | Filing → |